Segall Bryant & Hamill LLC Acquires 93,242 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Segall Bryant & Hamill LLC raised its stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 252.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 130,229 shares of the company's stock after acquiring an additional 93,242 shares during the period. Segall Bryant & Hamill LLC owned approximately 0.33% of Viemed Healthcare worth $948,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of VMD. Victory Capital Management Inc. raised its stake in shares of Viemed Healthcare by 45.8% in the first quarter. Victory Capital Management Inc. now owns 158,198 shares of the company's stock worth $1,152,000 after purchasing an additional 49,701 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in Viemed Healthcare by 12.2% in the first quarter. Bank of New York Mellon Corp now owns 80,141 shares of the company's stock valued at $583,000 after acquiring an additional 8,711 shares during the period. Mackenzie Financial Corp lifted its holdings in Viemed Healthcare by 225.5% in the fourth quarter. Mackenzie Financial Corp now owns 64,433 shares of the company's stock valued at $517,000 after acquiring an additional 44,636 shares during the period. Man Group plc bought a new position in Viemed Healthcare in the fourth quarter valued at about $95,000. Finally, Nuveen Asset Management LLC lifted its holdings in Viemed Healthcare by 22.1% in the fourth quarter. Nuveen Asset Management LLC now owns 162,272 shares of the company's stock valued at $1,301,000 after acquiring an additional 29,320 shares during the period. 74.24% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Nitin Kaushal sold 34,100 shares of the stock in a transaction that occurred on Friday, June 27th. The stock was sold at an average price of $7.01, for a total transaction of $239,041.00. Following the completion of the transaction, the director directly owned 126,843 shares of the company's stock, valued at approximately $889,169.43. This represents a 21.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 20.00% of the company's stock.

Viemed Healthcare Stock Performance

VMD traded down $0.04 during midday trading on Wednesday, reaching $6.46. The company had a trading volume of 262,890 shares, compared to its average volume of 147,431. The company has a quick ratio of 1.26, a current ratio of 1.38 and a debt-to-equity ratio of 0.03. The business has a 50-day moving average of $6.74 and a two-hundred day moving average of $7.23. The company has a market cap of $255.30 million, a P/E ratio of 21.53 and a beta of 1.37. Viemed Healthcare, Inc. has a 1 year low of $6.14 and a 1 year high of $9.81.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.06 EPS for the quarter, hitting analysts' consensus estimates of $0.06. The business had revenue of $59.10 million during the quarter, compared to analysts' expectations of $60.60 million. Viemed Healthcare had a return on equity of 9.49% and a net margin of 5.28%.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.